Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell

Sara C Martinez1, Corentin Cras-Méneur, Ernesto Bernal-Mizrachi

  • 1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8127, St. Louis, MO 63110, USA.

Diabetes
|May 30, 2006
PubMed

Insights

Glucose regulates Foxo1 activity in beta-cells via insulin signaling. This process involves insulin receptor activation, affecting Foxo1 phosphorylation and translocation, and ultimately influencing beta-cell function and metabolism.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Glucose is a key regulator of pancreatic islet beta-cell function and mass.
  • The phosphatidylinositol 3-kinase (PI3K)/Akt pathway, downstream of insulin signaling, plays a crucial role in glucose-mediated beta-cell control.
  • Foxo proteins are transcription factors regulated by Akt and influence cell proliferation and metabolism.

Purpose of the Study:

  • To investigate the hypothesis that glucose regulates Foxo1 activity in beta-cells through an autocrine/paracrine insulin signaling loop.
  • To elucidate the role of the insulin receptor in mediating glucose-induced Foxo1 regulation.
  • To identify Foxo1 targets and understand its transcriptional activity in response to nutritional changes.

Main Methods:

  • Utilized mouse insulinoma cells (MIN6) subjected to varying glucose concentrations and starvation.
  • Employed phosphorylation site-specific antibodies and Western blotting to assess Foxo1 phosphorylation.
  • Used inhibitors of depolarization, calcium influx, and PI3K signaling.
  • Performed nuclear-to-cytoplasmic translocation assays.
  • Conducted luciferase reporter assays to measure Foxo1 transcriptional activity and identify targets like Chop.
  • Generated an insulin receptor knockdown cell line to confirm the mediation pathway.

Main Results:

  • Glucose refeeding rapidly induced Foxo1 phosphorylation in MIN6 cells in a time- and dose-dependent manner.
  • Glucose-induced Foxo1 phosphorylation was dependent on depolarization, calcium influx, and PI3K signaling.
  • Increased glucose concentrations led to nuclear-to-cytoplasmic translocation of Foxo1.
  • The effects of glucose on Foxo1 were abolished in insulin receptor knockdown cells, highlighting the insulin receptor's critical role.
  • Foxo1 transcriptional activity increased with decreased glucose concentrations.
  • Chop was identified as a putative Foxo1 target gene.

Conclusions:

  • Nutritional alterations in beta-cells are associated with significant changes in Foxo1 transcriptional activity.
  • Glucose-stimulated insulin secretion, acting through the insulin receptor, predominantly mediates these changes in Foxo1 activity.
  • This signaling pathway is crucial for integrating metabolic cues and regulating beta-cell function and potentially mass.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...